Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong · Delayed Price · Currency is HKD 19.68
-0.78 (-3.81%)
Nov 13, 2026, 4:08 PM HKT
Giant Biogene Holding Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Giant Biogene Holding stock has a consensus rating of "Buy" and an average price target of $36.49. The average 1-year stock price forecast is 85.42% higher than the current stock price, while the lowest is $25.00 (+27.03%) and the highest is $46.00 (+133.74%).
Price Target: $36.49 (+85.42%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Giant Biogene Holding stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 13 | 13 | 12 | 11 | 11 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 17 | 17 | 18 | 17 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $43.00 | Buy | Reiterates | $43.00 | +118.50% | Oct 16, 2026 |
Unknown Analyst Orient Securities No rating | Orient Securities | Buy Maintains $43.07 → $45.53 | Buy | Maintains | $43.07 → $45.53 | +131.35% | Aug 27, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains $45.00 | Buy | Maintains | $45.00 | +128.66% | Aug 20, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $40.00 | Buy | Maintains | $40.00 | +103.25% | Aug 20, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $33.66 | Buy | Maintains | $33.66 | +71.04% | Aug 20, 2026 |
Financial Forecast
Revenue This Year
6.05B
from 5.52B
Increased by 9.71%
Revenue Next Year
6.81B
from 6.05B
Increased by 12.41%
EPS This Year
1.79
from 1.79
Decreased by -0.42%
EPS Next Year
1.92
from 1.79
Increased by 7.38%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.